Ranolazine | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Ranolazine
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Ranolazine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

57 API Suppliers, 28 USDMF, 17 EU WC, 2 KDMF, 22 NDC API, 39 Listed Suppliers, $ API Reference Price

57 API Suppliers
28 USDMF
17 EU WC
2 KDMF
22 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 54 FDA Orange Book, 28 Europe, 2 Canada, 22 Listed Dossiers

106 FDF Dossiers
54 FDA Orange Book
28 Europe
2 Canada
22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GRANULES, EXTENDED RELEASE;ORAL - 1GM, GRANULES, EXTENDED RELEASE;ORAL - 500MG

TABLET, EXTENDED RELEASE;ORAL - 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GRANULES, EXTENDED RELEASE;ORAL - 1GM
GRANULES, EXTENDED RELEASE;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 SPI Pharma, 2 DKSH, 2 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Clariant, 13 Corel Pharma Chem, 4 DFE Pharma, 10 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

64 Coating Systems & Additives, 41 Fillers, Diluents & Binders, 31 Controlled & Modified Release, 14 Solubilizers, 13 Film Formers & Plasticizers, 13 Direct Compression, 13 Thickeners and Stabilizers, 12 Lubricants & Glidants, 10 Granulation, 9 Parenteral, 8 Co-Processed Excipients, 7 Topical, 6 Disintegrants & Superdisintegrants, 6 Taste Masking, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids

64 Coating Systems & Additives
41 Fillers, Diluents & Binders
31 Controlled & Modified Release
14 Solubilizers
13 Film Formers & Plasticizers
13 Direct Compression
13 Thickeners and Stabilizers
12 Lubricants & Glidants
10 Granulation
9 Parenteral
8 Co-Processed Excipients
7 Topical
6 Disintegrants & Superdisintegrants
6 Taste Masking
5 Empty Capsules
5 API Stability Enhancers
5 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents
4 Rheology Modifiers
3 Surfactant & Foaming Agents
3 Chewable & Orodispersible Aids

DIGITAL CONTENT

26 NEWS #PharmaBuzz

26 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 25 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
25 Finished Drug Prices
8 Annual Reports

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

4 USP, 10 Others

4 USP
10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 83 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4SPIL

filter Patent Number Reset all filters

4 All

01 110898444

02 211510878

03 112161761

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 42038-01-24

Product Main Page

01

SPIL

BioAsia

Not Confirmed

SPIL

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-01-24

US Patent Number : 11510878

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216018

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-01-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SPIL

BioAsia

Not Confirmed

SPIL

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-01-24

US Patent Number : 12161761

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216018

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-01-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

SPIL

BioAsia

Not Confirmed

SPIL

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-01-24

US Patent Number : 10898444

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216018

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-01-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SPIL

BioAsia

Not Confirmed

SPIL

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-01-24

US Patent Number : 11510878

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 216018

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-01-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!